News

Pyrovanadates are deemed as an ideal class of potential Calcium ion storage hosts, owing to abundant confined species. However, the higher Coulombic hinderance brings about more sluggish diffusion ...
Pheast Therapeutics has treated the first subject in a multi-centre Phase I trial for the anti-cluster of differentiation 24 (CD24) macrophage checkpoint blocker PHST001, aimed at treating advanced ...
Slovenian scientists are pioneering a clean technology that uses recyclable metals instead of harmful chemical refrigerants ...